Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 42.76B | 37.06B | 33.14B | 30.26B | 31.56B |
Gross Profit | 9.23B | 7.83B | 6.56B | 5.95B | 5.57B |
EBITDA | 5.20B | 3.79B | 2.88B | 2.65B | 2.40B |
Net Income | 3.38B | 2.42B | 1.83B | 1.58B | 1.42B |
Balance Sheet | |||||
Total Assets | 30.20B | 26.83B | 23.02B | 21.93B | 20.05B |
Cash, Cash Equivalents and Short-Term Investments | 2.17B | 2.20B | 2.63B | 1.90B | 2.07B |
Total Debt | 14.00M | 22.00M | 30.00M | 41.00M | 5.00M |
Total Liabilities | 9.50B | 8.67B | 7.19B | 7.55B | 7.01B |
Stockholders Equity | 19.17B | 16.75B | 14.57B | 13.22B | 11.97B |
Cash Flow | |||||
Free Cash Flow | 2.86B | 3.42B | -771.00M | 2.30B | 717.00M |
Operating Cash Flow | 3.02B | 4.09B | -430.00M | 2.45B | 806.00M |
Investing Cash Flow | -2.10B | -2.76B | 1.25B | -2.32B | -1.22B |
Financing Cash Flow | -939.00M | -899.00M | -526.00M | -420.00M | -381.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | ¥49.96B | 10.92 | 2.98% | -14.87% | -0.65% | ||
76 Outperform | ¥102.56B | 11.86 | 2.10% | 15.78% | 20.79% | ||
76 Outperform | ¥21.82B | 9.83 | 4.41% | 8.75% | ― | ||
75 Outperform | ¥47.77B | 13.41 | 2.56% | 19.82% | 38.84% | ||
72 Outperform | ¥37.53B | 25.51 | 3.03% | 11.39% | -0.33% | ||
71 Outperform | ¥39.31B | 11.24 | 3.68% | 16.51% | 19.39% | ||
66 Neutral | £2.71B | 11.98 | 4.22% | 3.38% | 2.19% | -20.98% |